Published in Hum Mol Genet on July 01, 1999
KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway. Proc Natl Acad Sci U S A (2000) 2.45
Mice with altered KCNQ4 K+ channels implicate sensory outer hair cells in human progressive deafness. EMBO J (2006) 1.88
MYO6, the human homologue of the gene responsible for deafness in Snell's waltzer mice, is mutated in autosomal dominant nonsyndromic hearing loss. Am J Hum Genet (2001) 1.78
Deletion of the Ca2+-activated potassium (BK) alpha-subunit but not the BKbeta1-subunit leads to progressive hearing loss. Proc Natl Acad Sci U S A (2004) 1.67
Audioprofile-directed screening identifies novel mutations in KCNQ4 causing hearing loss at the DFNA2 locus. Genet Med (2008) 1.49
KV7 channelopathies. Pflugers Arch (2010) 1.20
A novel KCNQ4 pore-region mutation (p.G296S) causes deafness by impairing cell-surface channel expression. Hum Genet (2007) 1.14
Regulation of the voltage-gated potassium channel KCNQ4 in the auditory pathway. Pflugers Arch (2005) 1.13
DFNA8/12 caused by TECTA mutations is the most identified subtype of nonsyndromic autosomal dominant hearing loss. Hum Mutat (2011) 1.13
Determinants within the turret and pore-loop domains of KCNQ3 K+ channels governing functional activity. Biophys J (2008) 1.02
Ion channel gene expression in the inner ear. J Assoc Res Otolaryngol (2007) 1.01
The voltage-gated potassium channel subfamily KQT member 4 (KCNQ4) displays parallel evolution in echolocating bats. Mol Biol Evol (2011) 0.97
Cellular and molecular mechanisms of autosomal dominant form of progressive hearing loss, DFNA2. J Biol Chem (2010) 0.96
Inactivation as a new regulatory mechanism for neuronal Kv7 channels. Biophys J (2007) 0.95
Developmental expression of Kcnq4 in vestibular neurons and neurosensory epithelia. Brain Res (2007) 0.95
Autosomal dominant progressive sensorineural hearing loss due to a novel mutation in the KCNQ4 gene. Arch Otolaryngol Head Neck Surg (2011) 0.95
Therapeutic regulation of gene expression in the inner ear using RNA interference. Adv Otorhinolaryngol (2009) 0.94
An Examination of KCNE1 Mutations and Common Variants in Chronic Tinnitus. Genes (Basel) (2010) 0.93
Genetics of hearing loss: focus on DFNA2. Appl Clin Genet (2012) 0.90
Comprehensive genetic screening of KCNQ4 in a large autosomal dominant nonsyndromic hearing loss cohort: genotype-phenotype correlations and a founder mutation. PLoS One (2013) 0.88
Distribution of M-channel subunits KCNQ2 and KCNQ3 in rat hippocampus. Neuroimage (2011) 0.87
Screening of genetic alterations related to non-syndromic hearing loss using MassARRAY iPLEX® technology. BMC Med Genet (2015) 0.84
Deep resequencing of the voltage-gated potassium channel subunit KCNE3 gene in chronic tinnitus. Behav Brain Funct (2011) 0.83
Targeted high-throughput sequencing identifies pathogenic mutations in KCNQ4 in two large Chinese families with autosomal dominant hearing loss. PLoS One (2014) 0.82
KCNQ4 mutations associated with nonsyndromic progressive sensorineural hearing loss. Curr Opin Otolaryngol Head Neck Surg (2008) 0.82
Clue to a new deafness gene: a large Chinese nonsyndromic hearing loss family linked to DFNA4. J Genet Genomics (2012) 0.81
Pore size matters for potassium channel conductance. J Gen Physiol (2016) 0.80
Molecular biology of hearing. GMS Curr Top Otorhinolaryngol Head Neck Surg (2012) 0.80
KCNQ potassium channels in sensory system and neural circuits. Acta Pharmacol Sin (2015) 0.80
Identification of a novel in-frame deletion in KCNQ4 (DFNA2A) and evidence of multiple phenocopies of unknown origin in a family with ADSNHL. Eur J Hum Genet (2013) 0.79
Impaired surface expression and conductance of the KCNQ4 channel lead to sensorineural hearing loss. J Cell Mol Med (2013) 0.79
Restoration of ion channel function in deafness-causing KCNQ4 mutants by synthetic channel openers. Br J Pharmacol (2012) 0.79
In silico modeling of the pore region of a KCNQ4 missense mutant from a patient with hearing loss. BMC Res Notes (2012) 0.77
Progress and prospects in human genetic research into age-related hearing impairment. Biomed Res Int (2014) 0.77
Neuronal and Cardiovascular Potassium Channels as Therapeutic Drug Targets: Promise and Pitfalls. J Biomol Screen (2015) 0.77
Mechanisms of Calmodulin Regulation of Different Isoforms of Kv7.4 K+ Channels. J Biol Chem (2015) 0.76
Association of TMTC2 With Human Nonsyndromic Sensorineural Hearing Loss. JAMA Otolaryngol Head Neck Surg (2016) 0.75
Mapping of a new autosomal recessive non-syndromic hearing impairment locus (DFNB45) to chromosome 1q43-q44. Clin Genet (2008) 0.75
A novel pore-region mutation, c.887G > A (p.G296D) in KCNQ4, causing hearing loss in a Chinese family with autosomal dominant non-syndromic deafness 2. BMC Med Genet (2017) 0.75
Genetic and molecular analysis of the CLDN14 gene in Moroccan family with non-syndromic hearing loss. Indian J Hum Genet (2013) 0.75
The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell (1996) 15.19
TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell (1991) 10.06
Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell (1986) 7.34
The effect of amino acid analogues and heat shock on gene expression in chicken embryo fibroblasts. Cell (1978) 6.92
Quantitative trait locus for reading disability on chromosome 6. Science (1994) 6.07
Differential induction of heat shock, SOS, and oxidation stress regulons and accumulation of nucleotides in Escherichia coli. J Bacteriol (1987) 5.51
Perspectives on the basic reproductive ratio. J R Soc Interface (2005) 5.34
A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess (2007) 5.29
Antibodies to two major chicken heat shock proteins cross-react with similar proteins in widely divergent species. Mol Cell Biol (1982) 5.28
Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci U S A (1997) 4.73
Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell (1990) 4.60
Value-based pathology: a cost-benefit analysis of the examination of routine and nonroutine tonsil and adenoid specimens. Am J Clin Pathol (1997) 4.51
Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci U S A (1988) 4.40
Mutations in the connexin 26 gene (GJB2) among Ashkenazi Jews with nonsyndromic recessive deafness. N Engl J Med (1998) 4.34
Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J Med Genet (2002) 4.00
A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res (1998) 3.77
Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet (2001) 3.77
Mutations in the gene encoding B1 subunit of H+-ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet (1999) 3.73
Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. Cancer Res (1984) 3.67
Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci U S A (1988) 3.67
A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat Genet (1993) 3.58
Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther (1990) 3.55
Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23. Am J Hum Genet (2000) 3.48
Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci U S A (1991) 3.25
Characterization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel protein module, the WW domain. J Biol Chem (1995) 3.01
lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif. Cell (1989) 2.84
Nonsyndromic hearing impairment: unparalleled heterogeneity. Am J Hum Genet (1997) 2.82
The gut: a central organ after surgical stress. Surgery (1988) 2.76
Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest (1995) 2.66
Coordinate induction of alcohol dehydrogenase 1, aldolase, and other anaerobic RNAs in maize. J Biol Chem (1985) 2.63
Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA (1999) 2.56
Discrimination among thermophilic Campylobacter species by polymerase chain reaction amplification of 23S rRNA gene fragments. J Clin Microbiol (1993) 2.54
Mutations in the human alpha-tectorin gene cause autosomal dominant non-syndromic hearing impairment. Nat Genet (1998) 2.52
Anaerobic expression of maize fructose-1,6-diphosphate aldolase. J Biol Chem (1984) 2.51
Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss. Am J Hum Genet (1998) 2.51
Mutations in the novel protocadherin PCDH15 cause Usher syndrome type 1F. Hum Mol Genet (2001) 2.48
The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nat Genet (1993) 2.47
Congenital cytomegalovirus infection. N Engl J Med (1977) 2.35
Prevalent connexin 26 gene (GJB2) mutations in Japanese. J Med Genet (2000) 2.29
Quantitative-trait locus for specific language and reading deficits on chromosome 6p. Am J Hum Genet (1999) 2.26
Anaerobic expression of maize glucose phosphate isomerase I. J Biol Chem (1984) 2.24
Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science (1992) 2.19
Broadband observations of the naked-eye gamma-ray burst GRB 080319B. Nature (2008) 2.16
Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci U S A (1998) 2.13
A novel deletion involving the connexin-30 gene, del(GJB6-d13s1854), found in trans with mutations in the GJB2 gene (connexin-26) in subjects with DFNB1 non-syndromic hearing impairment. J Med Genet (2005) 2.11
TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol (1997) 2.11
The complexity of age-related hearing impairment: contributing environmental and genetic factors. Audiol Neurootol (2007) 2.09
A re-examination of risk estimates from the NIOSH Occupational Noise and Hearing Survey (ONHS) J Acoust Soc Am (1997) 2.09
Non-syndromic, autosomal-recessive deafness. Clin Genet (2006) 2.08
Congenital cytomegalovirus infection: diagnostic and prognostic significance of the detection of specific immunoglobulin M antibodies in cord serum. Pediatrics (1982) 2.07
Clinical studies of families with hearing loss attributable to mutations in the connexin 26 gene (GJB2/DFNB1) Pediatrics (1999) 2.05
The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol (1992) 2.03
Linkage of autosomal dominant hearing loss to the short arm of chromosome 1 in two families. N Engl J Med (1994) 2.03
Differential phosphorylation and localization of the transcription factor UBF in vivo in response to serum deprivation. In vitro dephosphorylation of UBF reduces its transactivation properties. J Biol Chem (1992) 2.02
A reliable method for evaluating drug compliance in children with cancer. Cancer (1979) 2.00
Common region on chromosome 14 in T-cell leukemia and lymphoma. Science (1984) 1.98
Oral challenge tests for urticaria--an ethical dilemma. Br J Dermatol (1994) 1.98
Connexin-26 mutations in sporadic non-syndromal sensorineural deafness. Lancet (1998) 1.97
Muscle-specific mutations accumulate with aging in critical human mtDNA control sites for replication. Proc Natl Acad Sci U S A (2001) 1.94
Specific reading disability: identification of an inherited form through linkage analysis. Science (1983) 1.94
Consensus for tinnitus patient assessment and treatment outcome measurement: Tinnitus Research Initiative meeting, Regensburg, July 2006. Prog Brain Res (2007) 1.93
Pattern formation in the blue-green alga, Anabaena. I. Basic mechanisms. J Cell Sci (1973) 1.92
Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest (1998) 1.91
Genetic influences on learning disabilities and speech and language disorders. Child Dev (1983) 1.90
Camptodactyly and simialr atraumatic flexion deformities of the proximal interphalangeal joints of the fingers. A study of thirty-one cases. J Bone Joint Surg Am (1968) 1.89
Fusion of an immunoglobulin variable gene and a T cell receptor constant gene in the chromosome 14 inversion associated with T cell tumors. Cell (1985) 1.87
Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol Endocrinol Metab (2001) 1.84
Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13). Nat Genet (1999) 1.82
Eye signs in craniopharyngioma. Br J Ophthalmol (1975) 1.80
Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade. Crit Care Med (2001) 1.78
Pattern formation in the blue-green alga Anabaena. II. Controlled proheterocyst regression. J Cell Sci (1973) 1.78
Recurrent meningitis and Mondini dysplasia. Arch Otolaryngol Head Neck Surg (1990) 1.77
Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations. Hum Mutat (2001) 1.77
Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet (2000) 1.76
Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res (1997) 1.76
Cloning and characterization of two members of the vertebrate Dlx gene family. Proc Natl Acad Sci U S A (1994) 1.76
In vitro synthesis of heat-shock proteins by mRNAs from chicken embryo fibroblasts. J Biol Chem (1980) 1.73
The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J Clin Endocrinol Metab (1998) 1.71
Genome digestion is a dispensable consequence of physiological cell death mediated by cytotoxic T lymphocytes. Mol Cell Biol (1992) 1.71
Glutamine metabolism by the intestinal tract. JPEN J Parenter Enteral Nutr (1985) 1.71
Teratogenicity of 2-ethoxyethanol by dermal application. Drug Chem Toxicol (1982) 1.70
Localization of the Usher syndrome type ID gene (Ush1D) to chromosome 10. Hum Mol Genet (1996) 1.69
Biochemical changes in the collagen of the palmar fascia in patients with Dupuytren's disease. J Bone Joint Surg Am (1981) 1.69
Non-syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutations. Hum Genet (1999) 1.69
Analysis of the phosphorylation, DNA-binding and dimerization properties of the RNA polymerase I transcription factors UBF1 and UBF2. Nucleic Acids Res (1992) 1.69
Assignment of a second locus for multiple exostoses to the pericentromeric region of chromosome 11. Hum Mol Genet (1994) 1.68
Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med (1992) 1.68